Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
TYRA

Tyra Biosciences (TYRA) stock: insider trades, news & valuation

Health Care · Net selling
Close · Oct 9, 2026 $19.94 -0.2% on the day +44.3% over 12 months 52-week range $13.52 – $39.61

Share price and insider trades

TYRA closeInsider buyInsider sale
10203040NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $17,776 on 2025-11-13 · Daniel BensenBought $20,002 on 2026-09-09 · Rehan VerjeeSold $181,120 on 2025-12-12 · Daniel BensenSold $228,171 on 2026-01-12 · Daniel BensenSold $250,000 on 2025-12-19 · Robert J MoreSold $262,981 on 2026-02-12 · Daniel BensenSold $324,800 on 2025-11-17 · Daniel BensenSold $528,486 on 2026-03-25 · Gilla KaplanSold $815,282 on 2025-11-19 · Daniel BensenSold $1,215,422 on 2025-11-18 · Daniel BensenSold $1,765,853 on 2025-11-14 · Daniel BensenSold $4,999,138 on 2025-11-21 · Robert J More
Bought, 12 months$20K
Sold, 12 months$10.6M
Insiders buying1
Insiders selling3

Tyra Biosciences insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $20K and 3 sold $10.6M of TYRA stock on the open market.

TYRA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $9.6M sold (9 trades)Q4 2025Q1 2026: $1.0M sold (5 trades)Q1 2026Q2 2026Q3 2026: $20K bought (1 trades)$20KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$20K1—0
Q2 2026—0—0
Q1 2026—0$1.0M5
Q4 2025—0$9.6M9

Valuation, profit and volume

Pick score 40/100
P/E (trailing)n/aSector median 24.7
Market value$1.37BBiotechnology
Profit margin0.0%Revenue growth —
Volume vs. 50-day0.7×Last 5 sessions
Insiders' paper profit−$622On all tracked purchases -3.1%

Summary

Over the past 12 months, 1 Tyra Biosciences, Inc. insider reported open-market purchases totaling $20K, while 3 insiders reported sales totaling $10.6M. 13 of 14 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

TYRA stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 11SEC Rehan VerjeeDirector Buy 972new position $20.58 $20K -3.1% —
Mar 27SEC Gilla KaplanDirector Sell 14,29528,231 held (−34%) $36.97 $528K -46.1% —
Feb 13SEC Daniel BensenChief Discovery Officer Sell Plan 5,872146,981 held (−4%) $33.37 $196K -40.2% —
Feb 13SEC Daniel BensenChief Discovery Officer Sell Plan 2,128152,853 held (−1%) $31.50 $67K -36.7% —
Jan 20SEC Daniel BensenChief Discovery Officer Sell Plan 6,983155,998 held (−4%) $28.44 $199K -29.9% —
Jan 20SEC Daniel BensenChief Discovery Officer Sell Plan 1,017154,981 held (−1%) $29.08 $30K -31.4% —
Dec 19SEC Robert J MoreDirector Sell Plan 10,0003,823,425 held (−0%) $25.00 $250K -20.2% —
Dec 16SEC Daniel BensenChief Discovery Officer Sell Plan 8,000162,981 held (−5%) $22.64 $181K -11.9% —
Nov 25SEC Robert J MoreDirector Sell Plan 246,8713,833,425 held (−6%) $20.25 $5.0M -1.5% —
Nov 19SEC Daniel BensenCOO Sell Plan 75,633220,937 held (−26%) $16.07 $1.2M +24.1% —
Nov 19SEC Daniel BensenCOO Sell Plan 49,956170,981 held (−23%) $16.32 $815K +22.2% —
Nov 17SEC Daniel BensenCOO Sell Plan 110,228316,642 held (−26%) $16.02 $1.8M +24.5% —
Nov 17SEC Daniel BensenCOO Sell Plan 18,572298,070 held (−6%) $16.11 $299K +23.8% —
Nov 17SEC Daniel BensenCOO Sell Plan 1,500296,570 held (−1%) $17.07 $26K +16.8% —
Nov 17SEC Daniel BensenCOO Sell Plan 1,111426,870 held (−0%) $16.00 $18K +24.6% —

Insiders at Tyra Biosciences, Inc.

InsiderBoughtSoldLast filingScore
Robert J MoreDirector — $5.2M Dec 19, 2025 —
Daniel BensenChief Discovery Officer — $4.8M Feb 13, 2026 —
Gilla KaplanDirector — $528K Mar 27, 2026 —
Rehan VerjeeDirector $20K — Sep 11, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

TYRA stock: common questions

Are Tyra Biosciences, Inc. insiders buying TYRA stock?

In the past 12 months, 1 insiders reported open-market purchases of TYRA worth $20K. The latest was Director Rehan Verjee bought $20K of TYRA at $20.58 — first open-market purchase in our records; opens a new position.

Are Tyra Biosciences, Inc. insiders selling TYRA stock?

3 insiders reported sales worth $10.6M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is TYRA's 52-week range?

Over the past year TYRA has traded between $13.52 and $39.61. It last closed at $19.94 on Oct 9, 2026.